2009
DOI: 10.1021/ja807711w
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Imaging and in Vivo Liver Targeting with Carbohydrate Capped Quantum Dots

Abstract: PEGylated quantum dots (QDs) capped with d-mannose, d-galactose, and d-galactosamine have been synthesized. The stable, high quantum yield fluorescence of QDs was exploited to study specific carbohydrate-protein interactions in vitro and in vivo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
150
0
4

Year Published

2010
2010
2016
2016

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 225 publications
(159 citation statements)
references
References 36 publications
3
150
0
4
Order By: Relevance
“…Although different types of nanomaterials including CdS/ZnS quantum dots, [33][34][35][36][37][38] upconverting nanoparticles, 39 magnetic nanoparticles, [40][41][42][43][44][45] and carbon nanotubes, 46 have been used for the synthesis of glyconanoparticles, the intrinsic colour changes associated with the aggregation of noble metal nanoparticles have ensured that these nanoparticles are extensively used for the development of bioassays.…”
Section: Noble Metals Used To Synthesise the Nanoparticle Corementioning
confidence: 99%
“…Although different types of nanomaterials including CdS/ZnS quantum dots, [33][34][35][36][37][38] upconverting nanoparticles, 39 magnetic nanoparticles, [40][41][42][43][44][45] and carbon nanotubes, 46 have been used for the synthesis of glyconanoparticles, the intrinsic colour changes associated with the aggregation of noble metal nanoparticles have ensured that these nanoparticles are extensively used for the development of bioassays.…”
Section: Noble Metals Used To Synthesise the Nanoparticle Corementioning
confidence: 99%
“…9,34,35 The cytotoxicity of different DOX formulations was studied by MTT assay, which measures mitochondrial function or integrity.…”
Section: Discussionmentioning
confidence: 99%
“…15 In active targeted therapy for HCC, galactose is considered to be a promising ligand because it can specifically recognize and bind asialoglycoprotein receptor, which is overexpressed exclusively on the surfaces of hepatic parenchymal cells. 16,17 Galactose has been conjugated to drug carriers to achieve targeted chemotherapeutic or diagnostic agent delivery to HepG2 cells overexpressing the asialoglycoprotein receptor, although the precise mechanism of asialoglycoprotein receptor-mediated uptake of galactose-modified carriers into HepG2 cells remains unresolved.…”
Section: Introductionmentioning
confidence: 99%